Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules

Christian Heiss1, Ioakim Spyridopoulos2, Judith Haendeler3

  • 1Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany.

Insights

Cardiovascular aging can be modulated by dietary and pharmacologic interventions. Research explores plant bioactives and lifestyle changes to improve vascular health and potentially extend lifespan.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Nutritional Science

Background:

  • Cardiovascular aging involves dynamic changes in function and structure.
  • These age-dependent vascular changes remain modifiable in older adults.
  • Interventions targeting specific signaling pathways show promise.

Purpose of the Study:

  • To review current approaches for improving age-dependent vascular changes.
  • To explore the role of dietary restriction and pharmacologic agents.
  • To assess the potential of nutritional strategies and plant bioactives.

Main Methods:

  • Review of literature on cardiovascular aging interventions.
  • Analysis of signaling pathways (TOR, GH/IGF-1, AMPK, sirtuins).
  • Evaluation of dietary approaches (Mediterranean diet, bioactives like flavanols, anthocyanins, lignins).

Main Results:

  • Dietary restriction and pharmacologic agents can modulate vascular aging.
  • Plant bioactives show potential in improving endothelial function, arterial stiffness, blood pressure, cholesterol, and glycemic control.
  • Mechanisms of action for many bioactives are not fully understood.

Conclusions:

  • Interventions targeting signaling pathways and nutritional approaches show promise for vascular healthy aging.
  • Further research is needed to elucidate the mechanisms of action of plant bioactives.
  • Determining if these interventions can reverse cardiovascular aging and increase healthspan/longevity in humans requires investigation.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
516
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
903
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
790
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
419